# The Drug-drug Interaction of SP2086 and Simvastatin

> **NCT02815722** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** SP2086
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT02815722
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02815722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02815722, "The Drug-drug Interaction of SP2086 and Simvastatin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02815722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*